NuCana plc Announces Pricing of Initial Public Offering
Released: Wednesday 27th September 2017
NuCana plc Announces Pricing of Initial Public Offering.
For more information click here
The voice of Scotland's life sciences industries
- Medannex Unveils Positive Clinical Data on MDX-124 at ESMO 2025
- Medannex’s Therapeutic Granted FDA Orphan Drug Designation for Biliary Tract Cancer
- BioAscent appoints Vice President of Alliance Management
- MEDANNEX UNVEILS NOVEL APPROACH TO OSTEOSARCOMA TREATMENT
- RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership
- All Members' News
© Scottish Lifesciences Association 2025
Scottish Lifesciences Association, 44 Charlotte Square, Edinburgh, EH2 4HQ, Scotland
Registered in Scotland - SC390602
Tel: +44 (0) 7753 312 263
